HEADER HYDROLASE 14-MAY-08 3D4F TITLE SHV-1 BETA-LACTAMASE COMPLEX WITH LN1-255 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE SHV-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PIT-2; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: BLA, SHV1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH10B; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBC SK(-) KEYWDS BETA-LACTAMASE INHIBITOR, DRUG DESIGN, ANTIBIOTIC RESISTANCE, KEYWDS 2 HYDROLASE, PLASMID EXPDTA X-RAY DIFFRACTION AUTHOR P.PATTANAIK,C.R.BETHEL,A.M.HUJER,R.A.BONOMO,J.D.BUYNAK,F.VAN DEN AUTHOR 2 AKKER REVDAT 3 09-OCT-24 3D4F 1 REMARK REVDAT 2 03-APR-24 3D4F 1 REMARK LINK REVDAT 1 10-FEB-09 3D4F 0 JRNL AUTH P.PATTANAIK,C.R.BETHEL,A.M.HUJER,K.M.HUJER,A.M.DISTLER, JRNL AUTH 2 M.TARACILA,V.E.ANDERSON,T.R.FRITSCHE,R.N.JONES,S.R.PAGADALA, JRNL AUTH 3 F.VAN DEN AKKER,J.D.BUYNAK,R.A.BONOMO JRNL TITL STRATEGIC DESIGN OF AN EFFECTIVE {BETA}-LACTAMASE INHIBITOR: JRNL TITL 2 LN-1-255, A 6-ALKYLIDENE-2'-SUBSTITUTED PENICILLIN SULFONE JRNL REF J.BIOL.CHEM. V. 284 945 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 18955486 JRNL DOI 10.1074/JBC.M806833200 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1336274.310 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 33435 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1659 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5188 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 278 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2024 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 248 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.29000 REMARK 3 B22 (A**2) : -4.05000 REMARK 3 B33 (A**2) : 0.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.15 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.080 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 53.59 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LN1-24HRS_D5.PAR REMARK 3 PARAMETER FILE 4 : NEW_CYMAL.PAR REMARK 3 PARAMETER FILE 5 : CIS167NEW.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NEW_LIGANDS_24HR_9.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3D4F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047578. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : VERTICALLY FOCUSING MIRROR AND A REMARK 200 HORIZONTALLY FOCUSING REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33525 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10100 REMARK 200 FOR THE DATA SET : 20.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: SHV-1 WT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG6000, 0.1M HEPES PH7. 0.56MM REMARK 280 CYMAL-6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.80550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.75100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.75150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.75100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.80550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.75150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 5 REMARK 465 ARG A 6 REMARK 465 TYR A 7 REMARK 465 ILE A 8 REMARK 465 ARG A 9 REMARK 465 LEU A 10 REMARK 465 CYS A 11 REMARK 465 ILE A 12 REMARK 465 ILE A 13 REMARK 465 SER A 14 REMARK 465 LEU A 15 REMARK 465 LEU A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 LEU A 21 REMARK 465 ALA A 22 REMARK 465 VAL A 23 REMARK 465 HIS A 24 REMARK 465 ALA A 25 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 69 -144.64 56.05 REMARK 500 TYR A 105 90.43 71.55 REMARK 500 VAL A 216 -83.03 -103.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MA4 A 401 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MA4 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MA4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LN1 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SHV RELATED DB: PDB REMARK 900 SHV-1 BETA-LACTAMASE STRUCTURE REMARK 900 RELATED ID: 1GA0 RELATED DB: PDB REMARK 900 INHIBITION OF CLASS C BETA-LACTAMASES: STRUCTURE OF A REACTION REMARK 900 INTERMEDIATE WITH A CEPHEM SULFONE DBREF 3D4F A 5 292 UNP P0AD64 BLA1_KLEPN 1 286 SEQRES 1 A 286 MET ARG TYR ILE ARG LEU CYS ILE ILE SER LEU LEU ALA SEQRES 2 A 286 THR LEU PRO LEU ALA VAL HIS ALA SER PRO GLN PRO LEU SEQRES 3 A 286 GLU GLN ILE LYS LEU SER GLU SER GLN LEU SER GLY ARG SEQRES 4 A 286 VAL GLY MET ILE GLU MET ASP LEU ALA SER GLY ARG THR SEQRES 5 A 286 LEU THR ALA TRP ARG ALA ASP GLU ARG PHE PRO MET MET SEQRES 6 A 286 SER THR PHE LYS VAL VAL LEU CYS GLY ALA VAL LEU ALA SEQRES 7 A 286 ARG VAL ASP ALA GLY ASP GLU GLN LEU GLU ARG LYS ILE SEQRES 8 A 286 HIS TYR ARG GLN GLN ASP LEU VAL ASP TYR SER PRO VAL SEQRES 9 A 286 SER GLU LYS HIS LEU ALA ASP GLY MET THR VAL GLY GLU SEQRES 10 A 286 LEU CYS ALA ALA ALA ILE THR MET SER ASP ASN SER ALA SEQRES 11 A 286 ALA ASN LEU LEU LEU ALA THR VAL GLY GLY PRO ALA GLY SEQRES 12 A 286 LEU THR ALA PHE LEU ARG GLN ILE GLY ASP ASN VAL THR SEQRES 13 A 286 ARG LEU ASP ARG TRP GLU THR GLU LEU ASN GLU ALA LEU SEQRES 14 A 286 PRO GLY ASP ALA ARG ASP THR THR THR PRO ALA SER MET SEQRES 15 A 286 ALA ALA THR LEU ARG LYS LEU LEU THR SER GLN ARG LEU SEQRES 16 A 286 SER ALA ARG SER GLN ARG GLN LEU LEU GLN TRP MET VAL SEQRES 17 A 286 ASP ASP ARG VAL ALA GLY PRO LEU ILE ARG SER VAL LEU SEQRES 18 A 286 PRO ALA GLY TRP PHE ILE ALA ASP LYS THR GLY ALA GLY SEQRES 19 A 286 GLU ARG GLY ALA ARG GLY ILE VAL ALA LEU LEU GLY PRO SEQRES 20 A 286 ASN ASN LYS ALA GLU ARG ILE VAL VAL ILE TYR LEU ARG SEQRES 21 A 286 ASP THR PRO ALA SER MET ALA GLU ARG ASN GLN GLN ILE SEQRES 22 A 286 ALA GLY ILE GLY ALA ALA LEU ILE GLU HIS TRP GLN ARG HET MA4 A 400 35 HET MA4 A 401 9 HET LN1 A 601 57 HETNAM MA4 CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE HETNAM LN1 (3R)-4-{[(3,4-DIHYDROXYPHENYL)ACETYL]OXY}-N-(2- HETNAM 2 LN1 FORMYLINDOLIZIN-3-YL)-3-SULFINO-D-VALINE FORMUL 2 MA4 2(C24 H44 O11) FORMUL 4 LN1 C22 H22 N2 O9 S FORMUL 5 HOH *248(H2 O) HELIX 1 1 GLN A 28 SER A 41 1 14 HELIX 2 2 THR A 71 ALA A 86 1 16 HELIX 3 3 ARG A 98 LEU A 102 5 5 HELIX 4 4 VAL A 108 HIS A 112 5 5 HELIX 5 5 VAL A 119 SER A 130 1 12 HELIX 6 6 ASP A 131 VAL A 142 1 12 HELIX 7 7 GLY A 143 ILE A 155 1 13 HELIX 8 8 THR A 167 GLU A 171 5 5 HELIX 9 9 THR A 182 SER A 196 1 15 HELIX 10 10 SER A 200 ASP A 213 1 14 HELIX 11 11 VAL A 216 LEU A 225 1 10 HELIX 12 12 SER A 271 HIS A 289 1 19 SHEET 1 A 5 THR A 56 TRP A 60 0 SHEET 2 A 5 ARG A 43 ASP A 50 -1 N MET A 46 O TRP A 60 SHEET 3 A 5 ARG A 259 ARG A 266 -1 O ILE A 260 N MET A 49 SHEET 4 A 5 ARG A 244 GLY A 251 -1 N ALA A 248 O VAL A 261 SHEET 5 A 5 PHE A 230 ALA A 237 -1 N PHE A 230 O GLY A 251 SHEET 1 B 2 PHE A 66 PRO A 67 0 SHEET 2 B 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 C 2 LYS A 94 ILE A 95 0 SHEET 2 C 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SSBOND 1 CYS A 77 CYS A 123 1555 1555 2.06 LINK OG SER A 70 C7 LN1 A 601 1555 1555 1.37 CISPEP 1 GLU A 166 THR A 167 0 0.48 SITE 1 AC1 14 ARG A 93 ILE A 95 HIS A 96 ARG A 98 SITE 2 AC1 14 PRO A 226 ALA A 280 ALA A 284 GLU A 288 SITE 3 AC1 14 HOH A 614 HOH A 658 HOH A 686 HOH A 767 SITE 4 AC1 14 HOH A 797 HOH A 798 SITE 1 AC2 2 ARG A 244 ILE A 279 SITE 1 AC3 14 SER A 70 TYR A 105 SER A 130 ASN A 132 SITE 2 AC3 14 LEU A 220 LYS A 234 THR A 235 GLY A 236 SITE 3 AC3 14 ALA A 237 ARG A 244 ASN A 276 HOH A 690 SITE 4 AC3 14 HOH A 736 HOH A 794 CRYST1 49.611 55.503 83.502 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020157 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018017 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011976 0.00000